Biocon jumps on receiving EIR from USFDA for manufacturing facility in Bengaluru

20 Mar 2020 Evaluate

Biocon is currently trading at Rs. 261.00, up by 8.45 points or 3.35% from its previous closing of Rs. 252.55 on the BSE.

The scrip opened at Rs. 259.80 and has touched a high and low of Rs. 262.55 and Rs. 253.70 respectively. So far 49711 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 323.30 on 24-Feb-2020 and a 52 week low of Rs. 211.30 on 20-Aug-2019.

Last one week high and low of the scrip stood at Rs. 287.35 and Rs. 235.80 respectively. The current market cap of the company is Rs. 31266.00 crore.

The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 21.64% and 17.70% respectively.

Biocon has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) for the Post-Approval and GMP inspection of its Small Molecules API Manufacturing Facility at 20th KM, Biocon Campus, Bengaluru, conducted between February 20, 2020 and February 26, 2020.

The EIR has been closed with a VAI classification for the observations. At the conclusion of the inspection in February, the agency had issued a Form 483, with two observations, which were procedural in nature and are being addressed by the company.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

368.45 3.20 (0.88%)
28-Jan-2026 12:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1616.15
Dr. Reddys Lab 1220.30
Cipla 1315.70
Zydus Lifesciences 891.85
Lupin 2118.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×